DIVISLAB logo

DIVI S Laboratories LTD

F&O
DIVISLAB·NSE·
9,228.50 +8.50 (+0.09%)
Market Cap244771.28 Cr
PE Ratio95.40
Volume46,256
Day High - Low9264.50 - 9188.00
52W High-Low9467.00 - 5636.50
DocStoX Score
5.7/10
Fair
Fair Value
Sign in to see
ROE
16.50%
Strong
P/E
95.40x
Expensive
Debt / Equity
0.00
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

NIFTY NEXT 50NIFTY 100NIFTY 200
Day9188
9265
52W5637
9467
DocStoX take

Supported by risk (9.8) and quality (7.5), but held back by valuation (0.0). Risk looks strong at 9.8, but that is offset by valuation at 0.0. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
5.7
/10
Fair
Quality
Excellent
ROE 16.5%
Valuation
Expensive
P/E 95.4×
Growth
Slow
Revenue +8.7% 5Y CAGR
Risk
Low risk
D/E 0.00
Momentum
Strong
94% of 52-week range

At a glance

Market Cap
₹2.45L Cr
52W High / Low
₹9467 / ₹5637
Dividend Yield
0.33%
Promoter Holding
51.88%
EPS (TTM)
₹96.73
Book Value
₹631.00

Key highlights

  • Low leverage — D/E 0.00
  • Profitable in all of the last 5 years
  • Healthy net margin (24%)
  • Valuation is weak (0.0/10)
  • Expensive at 95× earnings
4 Positives2 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

DIVI S LABORATORIES LTD peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.

DIVI S LABORATORIES LTD (DIVISLAB) Share Price at ₹9,228.5 (+0.09%) | DocStoX